Ingevity Corporation manufactures and sells specialty chemicals and activated carbon materials in North America, Europe, the Asia-Pacific, and internationally.
Undervalued with acceptable track record.
Share Price & News
How has Ingevity's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: IGX's share price has been volatile over the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: IGX underperformed the German Chemicals industry which returned -33% over the past year.
Return vs Market: IGX underperformed the German Market which returned -17.2% over the past year.
Price Volatility Vs. Market
How volatile is Ingevity's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Is Ingevity undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: IGX (€30.6) is trading below our estimate of fair value (€68.58)
Significantly Below Fair Value: IGX is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: IGX is good value based on its PE Ratio (8x) compared to the Chemicals industry average (13.7x).
PE vs Market: IGX is good value based on its PE Ratio (8x) compared to the German market (16.8x).
Price to Earnings Growth Ratio
PEG Ratio: IGX is good value based on its PEG Ratio (0.8x)
Price to Book Ratio
PB vs Industry: IGX is overvalued based on its PB Ratio (2.8x) compared to the DE Chemicals industry average (1.2x).
How is Ingevity forecast to perform in the next 1 to 3 years based on estimates from 9 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: IGX's forecast earnings growth (10.2% per year) is above the savings rate (-0.4%).
Earnings vs Market: IGX's earnings (10.2% per year) are forecast to grow slower than the German market (14.5% per year).
High Growth Earnings: IGX's earnings are forecast to grow, but not significantly.
Revenue vs Market: IGX's revenue (3.2% per year) is forecast to grow slower than the German market (4.1% per year).
High Growth Revenue: IGX's revenue (3.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if IGX's Return on Equity is forecast to be high in 3 years time
How has Ingevity performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: IGX has high quality earnings.
Growing Profit Margin: IGX's current net profit margins (14.2%) are lower than last year (14.9%).
Past Earnings Growth Analysis
Earnings Trend: IGX's earnings have grown by 18% per year over the past 5 years.
Accelerating Growth: IGX's earnings growth over the past year (8.6%) is below its 5-year average (18% per year).
Earnings vs Industry: IGX earnings growth over the past year (8.6%) exceeded the Chemicals industry -8.9%.
Return on Equity
High ROE: Whilst IGX's Return on Equity (34.61%) is high, this metric is skewed due to their high level of debt.
How is Ingevity's financial position?
Financial Position Analysis
Short Term Liabilities: IGX's short term assets ($463.2M) exceed its short term liabilities ($215.5M).
Long Term Liabilities: IGX's short term assets ($463.2M) do not cover its long term liabilities ($1.4B).
Debt to Equity History and Analysis
Debt Level: IGX's debt to equity ratio (221.3%) is considered high.
Reducing Debt: IGX's debt to equity ratio has increased from 0.7% to 221.3% over the past 5 years.
Debt Coverage: IGX's debt is well covered by operating cash flow (23.5%).
Interest Coverage: IGX's interest payments on its debt are well covered by EBIT (6.6x coverage).
Inventory Level: IGX has a high level of physical assets or inventory.
Debt Coverage by Assets: IGX's debt is not covered by short term assets (assets are 0.4x debt).
What is Ingevity's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate IGX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate IGX's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if IGX's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if IGX's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of IGX's dividend in 3 years as they are not forecast to pay a notable one for the German market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Rick Kelson (72yo)
Mr. Richard B. Kelson, also known as Rick, J.D. is Interim Chief Executive Officer and Interim President at Ingevity Corporation since February 20, 2020. He has been the Chief Executive Officer of ServCo, ...
|Chairman of the Board and Interim President & CEO||0.17yr||US$265.09k||0.021% $287.5k|
|Executive VP||5.25yrs||US$2.67m||0.096% $1.3m|
|Executive VP||5.25yrs||US$1.40m||0.030% $418.5k|
|Executive VP & President of Performance Materials||5.25yrs||US$1.31m||0.027% $371.1k|
|Executive VP and President of Performance Chemicals||3.25yrs||US$1.21m||0.028% $390.4k|
|Senior Vice President of Operations||no data||no data||no data|
|Chief Accounting Officer & Corporate Controller||3.92yrs||no data||0.0058% $81.0k|
|Vice President of Investor Relations||no data||no data||no data|
|Vice President of Communications & Brand Management||no data||no data||no data|
|Senior Vice President of Human Resources||no data||no data||no data|
Experienced Management: IGX's management team is considered experienced (4.6 years average tenure).
|Chairman of the Board and Interim President & CEO||0.17yr||US$265.09k||0.021% $287.5k|
|Independent Director||1.17yrs||US$203.94k||0.0025% $34.9k|
|Independent Director||3.92yrs||US$200.09k||0.021% $297.1k|
|Independent Director||3.92yrs||US$192.09k||0.016% $225.5k|
|Independent Director||3.92yrs||US$180.09k||0.022% $303.5k|
|Independent Director||3.92yrs||US$180.09k||0.026% $365.3k|
|Lead Independent Director||0.17yr||US$195.09k||0.026% $363.6k|
|Independent Director||1.17yrs||US$203.94k||0.0049% $68.3k|
Experienced Board: IGX's board of directors are considered experienced (3.9 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: IGX insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Ingevity Corporation's company bio, employee growth, exchange listings and data sources
- Name: Ingevity Corporation
- Ticker: IGX
- Exchange: DB
- Founded: 2015
- Industry: Specialty Chemicals
- Sector: Materials
- Market Cap: US$1.521b
- Listing Market Cap: US$1.391b
- Shares outstanding: 41.83m
- Website: https://www.ingevity.com
Number of Employees
- Ingevity Corporation
- 5255 Virginia Avenue
- North Charleston
- South Carolina
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|NGVT||NYSE (New York Stock Exchange)||Yes||Commmon Stock||US||USD||May 2016|
|NGVT *||BMV (Bolsa Mexicana de Valores)||Yes||Commmon Stock||MX||MXN||May 2016|
|IGX||DB (Deutsche Boerse AG)||Yes||Commmon Stock||DE||EUR||May 2016|
Ingevity Corporation manufactures and sells specialty chemicals and activated carbon materials in North America, Europe, the Asia-Pacific, and internationally. The company operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products primarily for use in gasoline vapor emission control systems in cars, trucks, motorcycles, and boats. This segment also produces other activated carbon products for use in various applications, including food, water, beverage, and chemical purification. The Performance Chemicals segment develops, manufactures, and sells a range of specialty chemicals derived from co-products of the kraft pulping process and caprolactone monomers. This segment’s products are used in various applications comprising pavement preservation, pavement adhesion promotion, and warm mix paving; oil well service additives, oil production, and downstream application chemicals; printing inks, adhesives, agrochemicals, lubricants, and industrial intermediates; and coatings, resins, elastomers, and bio-plastics. Ingevity Corporation was incorporated in 2015 and is headquartered in North Charleston, South Carolina.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/04/03 03:04|
|End of Day Share Price||2020/04/02 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.